Spermosens AB (XSAT:SPERM) Total Stockholders Equity: kr27.45 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Spermosens AB Total Stockholders Equity?

Spermosens AB XSAT:SPERM Total Stockholders Equity is kr27.45 Mil as of Jun. 2026. The stock has 1 warning sign investors should review.

Spermosens AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr27.45 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Spermosens AB's Book Value per Share for the quarter that ended in Jun. 2026 was kr0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Spermosens AB's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

Spermosens AB  (XSAT:SPERM) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Spermosens AB's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(27.45-0)/3173.024065
=0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Spermosens AB's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 27.45
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spermosens AB Total Stockholders Equity Related Terms

Spermosens AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Spermosens AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spermosens AB Total Stockholders Equity Chart

Spermosens AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 23.64 5.83 12.69 22.86 32.41

Spermosens AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.88 34.52 32.41 30.24 27.45
What does a Total Stockholders Equity of kr27.45 Mil mean?
Spermosens AB (XSAT:SPERM) has a Total Stockholders Equity of kr27.45 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Spermosens AB and its competitors.
Is Spermosens AB's Total Stockholders Equity too high?
Spermosens AB's current Total Stockholders Equity is kr27.45 Mil.
How does Spermosens AB's Total Stockholders Equity compare to TMO and DHR?
Spermosens AB's Total Stockholders Equity of kr27.45 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Spermosens AB and its competitors. Spermosens AB's current Total Stockholders Equity is kr27.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spermosens AB stock overvalued right now?
Spermosens AB (XSAT:SPERM) has a current Total Stockholders Equity of kr27.45 Mil. The current Total Stockholders Equity is kr27.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Spermosens AB (XSAT:SPERM), the current Total Stockholders Equity is kr27.45 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spermosens AB Business Description

Other Exchanges 9R5:Germany
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.